Novel chiral skeletons for drug discovery: antibacterial tetramic acids. - Wikidata - wikimedia - TriplyDB

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

http://www.wikidata.org/entity/Q33893201

about

Chiral bicyclic tetramates as non-planar templates for chemical library synthesis.Synthesis of 3-acyltetramates by side chain manipulation and their antibacterial activity.A detailed study of antibacterial 3-acyltetramic acids and 3-acylpiperidine-2,4-diones.Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum.Aldol reactions in multicomponent reaction based domino pathways: a multipurpose enabling tool in heterocyclic chemistry Fused-Ring Oxazolopyrrolopyridopyrimidine Systems with Gram-Negative Activity.Biomimetic synthesis, antibacterial activity and structure-activity properties of the pyroglutamate core of oxazolomycin.Mimics of pramanicin derived from pyroglutamic acid and their antibacterial activity.Synthesis of a novel fused pyrrolodiazepine-based library with anti-cancer activity.

P2860

Q34563803-C4E06979-9576-42F6-91C2-A32251774C62 Q35090265-F2758D86-B30C-498F-82CE-0705F6FA3157 Q35170621-E6A439B8-313D-45F8-9AFD-E91E294E462E Q36218793-EBF5E58E-F07E-4398-BB8C-FC2D5D2BFE42 Q37056185-482EEEDC-36BE-43C5-A607-92B080FF20A5 Q42160840-38F536C0-3851-4017-9988-9445CFD6E08C Q47995007-3DDA2154-8CA4-4741-9B45-C29BB67D8365 Q48267872-A0643995-6B3C-43AB-88C1-113D909E0704 Q52611710-93F64AEE-AF94-4075-9E64-B2583D85D817

P2860

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

http://www.wikidata.org/entity/Q33893201

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

@ast

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

@en

type

label

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

@ast

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

@en

prefLabel

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

@ast

Novel chiral skeletons for drug discovery: antibacterial tetramic acids.

@en

P1433

Q33893201-1E5E2C5A-3A85-45EF-A298-55D04E570E13

P1476

Q33893201-C1600F92-AA91-412A-85AE-92F690C8DEF8

P2093

Q33893201-30713323-7C54-49F4-A7C3-C8A53307C392

Q33893201-3D8ED38F-5299-433E-96DE-07E9915DC49B

Q33893201-B758A0DF-3112-43C3-8639-CE7B5E5808D6

Q33893201-DBA160E0-D88B-405F-89C9-DB53B684B8EA

P2860

Q33893201-1A306D58-C43A-4D1C-BEF4-C7D8D4CEBB59

Q33893201-2A339901-A18F-4591-9B0E-3A9320E1295F

Q33893201-2A8B2020-8D34-4190-9784-1C3EF05BC0C9

Q33893201-34AB97E8-FC0F-4E73-943F-47D479C33F9C

Q33893201-3ABD513F-7602-4C8C-9947-87C786DF2E62

Q33893201-40429D0E-CB17-4775-9B6B-B542C01166E9

Q33893201-63A3783C-B71D-4623-87CC-00CBC997DEEE

Q33893201-661B3E16-2ED1-4E9D-8734-674F3702400C

Q33893201-66623D87-1DA4-41A4-A264-916E6CA111BD

Q33893201-66814643-ABE9-4B79-A71A-BFE1A228EDF7

P304

Q33893201-B93BCA17-0F47-4DDA-8059-C9F959AD491C

P31

Q33893201-75E1B843-8C81-4CB0-8C16-1894DAEEC30E

P356

Q33893201-F0FCD45C-A914-4078-A8A1-7813F0A52C8C

P433

Q33893201-AEC974A1-DB7A-410A-81B5-E7E79625B54F

P478

Q33893201-2947F5A8-DB94-4A21-B282-0AD983AE244B

P50

Q33893201-6252072D-0ACF-48B0-B4BF-0C8FE2C01F6D

Q33893201-E6F3C65F-4862-457B-999F-597C4D41B6B9

P577

Q33893201-48123D4B-5805-4805-A93C-616AB5C7A595

P5875

Q33893201-6B5E2AF9-114B-422C-B0FB-1E2AB6A08C45

P698

Q33893201-93DB98CD-DCB9-418C-9489-022208362EB7

P356

J.1747-0285.2011.01133.X

P1433

Chemical Biology and Drug Design

P1476

Novel chiral skeletons for drug discovery: antibacterial tetramic acids

@en

P2093

Chloe A Holloway

http://www.w3.org/2001/XMLSchema#string

Christine F Roberts

http://www.w3.org/2001/XMLSchema#string

Muhammad Yaqoob

http://www.w3.org/2001/XMLSchema#string

Yong-Chul Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Structures of RNA polymerase-antibiotic complexes

Recent developments in fragment-based drug discovery

Discovery and optimization of antibacterial AccC inhibitors

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Evaluation of a fast implicit solvent model for molecular dynamics simulations

Antibacterial natural products in medicinal chemistry--exodus or revival?

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

Drugs for bad bugs: confronting the challenges of antibacterial discovery

From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries.

Developing a drug-like natural product library.

P304

229-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1747-0285.2011.01133.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Mark G. Moloney

Christopher J Matthews

P577

2011-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51109773

http://www.w3.org/2001/XMLSchema#string

P698

21554556

http://www.w3.org/2001/XMLSchema#string